Introduction
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are effective chemopreventive agents for colorectal adenomas and cancer (1) (2) (3) (4) . The main targets of NSAIDs are the COX-1 and COX-2 proteins, which catalyze the first step in the prostaglandin synthesis pathway. This pathway metabolizes omega-6 (n-6) and n-3 poly-unsaturated fatty acids into prostaglandins, many of which are potent inflammatory mediators. Prostaglandin E 2 (PGE 2 ), one of the main downstream products of COX metabolism, is upregulated in colon cancer (5) and is associated with increased cell proliferation, survival, and motility (6) (7) (8) . Apc Min mice treated with PGE 2 have increased intestinal tumor number and size, compared to untreated mice (9) .
Conversely, PGE 2 receptor knockout mice show reduced intestinal tumorigenesis (10) (11) (12) . PGE 2 is produced by prostaglandin E 2 synthase, of which there are three forms (13) . One of these, microsomal prostaglandin E 2 synthase-1 (PGES), is induced by pro-inflammatory stimuli and is preferentially coupled to COX-2 over COX-1 in several tissues (14) . PGES is overexpressed in colorectal adenomas and cancer (13, 15) , and transfection of PGES in concert with COX-2 resulted in faster growth, increased cell aggregation, and abnormal cell morphology (16) , indicating that induction of PGES may be driving prostaglandin-related inflammatory processes. PGE 2 signals through four G-protein-coupled cell-surface receptors, referred to as EP1-4.
The four receptor types have different downstream mechanisms of signal transduction, resulting in a wide variety of functions, although EP2 and EP4 have similar modes of action (17) . Of the four EP receptors, EP2 and EP4 have been the most consistently linked to colorectal carcinogenesis (10, 12, 17, 18) . APC Δ716 /EP2-receptor-null mice had fewer intestinal polyps, reduced tumor growth, and reduced angiogenesis (10, 11, 19) , indicating that PGE 2 signaling through this receptor is an important contributor to colorectal neoplasia. Higher EP2 expression was associated with poorer colorectal cancer survival in a study of 99 Swedish cancer patients (18) . 4 In mouse models, knocking out EP4, either through genetic deletion or through treatment with an EP4-receptor antagonist reduced the formation of aberrant crypt foci and decreased polyp formation (12) . In an in vitro study, treatment of cells with an EP4 agonist countered the chemopreventive effects of NSAID treatment (20) , indicating that PGE 2 signaling through the EP4 receptor also plays an important role in the development of colorectal neoplasia. However, in mouse models of colitis, a condition predisposing to colorectal cancer, treatment with EP4 agonists ameliorates symptoms (21, 22) , indicating that the full extent of the relationship between EP4 and colon carcinogenesis is not yet well understood.
Prostaglandins can be inactivated by 15-hydroxyprostaglandin dehydrogenase (PGDH) (23) . APC Min -/-mice exhibit lower PGDH expression than APC Min +/-mice, and Pgdh knockout mice have greatly increased tumor development (24, 25) . Human colon cancer cell lines exhibit low levels of PGDH expression compared to normal colon mucosa (24, 26) , and expression of PGDH mRNA in human colon cancer tissues is greatly reduced compared to normal colon tissue (24) (25) (26) . PGDH expression is also reduced in inflammatory bowel disease (27) , a condition associated with markedly increased colorectal cancer risk.
Use of NSAIDs substantially reduces PGE 2 levels (28-30), induces PGDH expression (24, 31, 32) , and may decrease expression of EP2 (33) , indicating that reduction of PGE 2 production or signaling may be important mechanisms by which NSAIDs prevent colorectal neoplasia. Dietary factors also can influence prostaglandin levels. n-3 PUFAs, such as eicosapentaenoic acid, compete with arachidonic acid for metabolism by the prostaglandin pathway, resulting in production of 3-series prostaglandins that have reduced inflammatory potential (34) (35) (36) . Thus, higher intakes of n-3 fatty acids, which are abundant in fatty fish, may also result in reduced risk of colorectal adenoma or cancer.
Given the known relevance of this pathway to colorectal carcinogenesis, we evaluated genetic variability in key proteins related to PGE 2 synthesis, inactivation, and signaling in 5 relation to colorectal polyp risk. We have previously shown that genetic variability in the prostaglandin synthesis pathway may alter the chemopreventive associations between adenoma risk and NSAID use or fish intake (a proxy for n-3 polyunsaturated fatty acid intake) (37) (38) (39) (40) . We and others have screened the coding regions of PGES, EP2, and EP4 for polymorphisms (41, 42) . We investigated potential associations between tagSNPs in PGES, EP2, EP4, and PGDH, as well as two rare candidate non-synonymous SNPs (nsSNPs) in EP4, and risk of colorectal adenoma. We further explored potential interactions between these polymorphisms and use of aspirin or other NSAIDs and fish intake.
Materials and Methods
Study Population. Participant recruitment has been previously described (4, 43, 44 (49) to cover 85% of the common (≥4% MAF) variation in these loci (see Supplemental Table S1 ). A total of 51 SNPs successfully converted to the Illumina™ GoldenGate genotyping platform. Most of the polymorphisms that failed to convert (10/13) were "singleton" SNPs, not tagging for any 7 other polymorphisms; the three failed SNPs that tagged "bins" of LD, as well as two candidate polymorphisms, were subsequently genotyped individually at FHCRC (see below). call rate, <85% concordance with blinded or non-blinded duplicates, or Hardy-Weinberg Equilibrium p<0.0001 (see Supplemental Table S1 ). Eight tagSNPs were excluded due to quality control errors; leaving a total of 46 tagSNPs and two candidate SNPs in four genes included in the analyses presented here.
Genotyping

Statistical Analysis.
Single SNP Analyses: Unconditional, logistic regression was used to estimate the odds postmenopausal hormone use, and smoking. Because of possible racial differences in genotype frequencies, our analyses were restricted to Caucasian individuals (97% of the total study population). To obtain tests for trend, the genotypes were treated as a continuous variable, with the wildtype genotypes coded as 0, the heterozygous as 1, and the homozygous variant as 2.
All statistical analyses were carried out using SAS v.9. As a secondary analysis, pvalues were adjusted for multiple testing taking into account correlated tagSNPs using the p(ACT) method (50) . We corrected for multiple testing on the gene level, i.e. all tests within a gene were corrected for the total number of SNPs within a gene.
Whole gene analyses: Haplotype analysis and principal components analysis (PCA)
were used to evaluate the combined association of tagSNPs on a gene level (i.e. all SNPs in a gene were analyzed together). Haplotypes blocks were determined in Haploview (51) using the Gabriel method (52); the resulting blocks were individually analyzed in R v.2.8.0 using a modified version of the haplo.stats package (53), which allows adjustment for age and sex. All haplotypes with more than 5% frequency in the controls were included in the logistic regression models as a categorical variable; haplotypes with less than 5% frequency were grouped and included in the model as one variable. The most common haplotype among the controls was used as the referent group. Gene-level significance was determined using a score test of the haplotypes included in the model.
For PCA (54), we determined the number of principal components that explained at least 80% of the variance in adenoma risk and performed logistic regression using those major components, adjusted for age and sex. The gene-level significance was determined using a likelihood ratio test comparing a model that contained the principal components and one that did not.
Gene-gene interactions:
We evaluated gene-gene interactions using two methods: 1) the Tukey 1df interaction test proposed by Chatterjee et al (55) and 2) logic regression (56) . For the Chatterjee method, we performed the test of interaction in two ways: 1) by deriving scores for each parameter and then testing the maximum score against the normal distribution (i.e.
asymptote-based testing); or 2) by permutation-testing. Logic regression is a model selection method that uses Boolean logic to find combinations of variables that predict the outcome variable (56) . For the purposes of these comparisons, we ran models of various sizes to compare the fit and we also have performed Monte Carlo logic regression (57) to obtain a list of SNPs that show up frequently in the best fitting model, suggesting that these SNPs might be important predictors of disease risk. All gene-gene interaction analyses were conducted in R (version 2.8.0).
Results
Characteristics of the study population have been described previously (4, 43, 58) and are shown for the genotyped subset in ). An increase in risk was also observed for the homozygous variant genotype group; however, this was not statistically significant (Table 2 ).
For PGDH, we observed two associations of marginal statistical significance ( Table 3 ). 0.87; 95% CI: 0.58-1.31), whereas among those with at least one Ile allele, higher fish intake was associated with substantially increased adenoma risk (p-trend interaction=0.01; Table 4 ).
However, the EP4 Val294Ile is a rare polymorphism and the numbers of subjects with a variant allele were very small (n= 44), indicating that this interaction requires confirmation in a larger population.
For PGDH 31659T>C (3' UTR), no association with fish intake was observed among those with the common genotype. Those with the heterozygous or homozygous variant genotypes had a reduced adenoma risk with increasing weekly fish intake (p-trend interaction=0.02; were EP4 -1307G>A, which occurred with a frequency of 13.3% and EP2 4950G>A, which occurred with a frequency of 7.3%; these were the only SNPs that occurred with a frequency greater than 5%. Our finding that no single SNP was selected for inclusion in more than 15% of fitted models indicates that none of the SNPs we genotyped in these four genes is strongly related to risk of adenoma. This reflects the main SNP association findings, in which we detected very few statistically significant main associations.
Discussion
We investigated genetic variability in a biochemical pathway that has been unequivocally linked to colorectal carcinogenesis and has not yet been previously studied in the context of colorectal adenoma. Our results indicate that genetic variability related to PGE 2 signaling is generally not related to risk of colorectal adenoma. However, some data from this study suggest that genetic variability in PGES, EP2, EP4, or PGDH may alter the anti-inflammatory effects of 13 specific fatty acids or NSAID use. We hypothesized that NSAID use or high fish intake would be associated with lower risk of colorectal neoplasia, predominantly among those with genetic variants that are likely to increase PGE 2 production or signaling. We observed a statistically significant association for a tagSNP in EP2 and in EP4, but no other associations between tagSNPs in PGES or PGDH and risk of colorectal adenomas. Further, we observed several statistically significant or marginally significant interactions with NSAID use or fish intake, indicating that the consequences of genetic variability in prostaglandin synthesis may be further modified by underlying dietary or pharmacologic pro-or anti-inflammatory profiles. For the tagSNPs that were associated with adenoma risk or interacted with inflammatory exposures, we investigated their LD with any potentially functional SNPs (Supplemental Table S9 ) by evaluating SNP locations, regulatory regions, and conservation across species. However no SNPs with clear functional significance were identified.
To our knowledge, no previous studies have examined associations between genetic variants in PGES, EP2, EP4, and PGDH and risk of adenoma. However, although our findings require confirmation in additional studies, our results suggest similar patterns to previous reports on interactions between polymorphisms in COX-1, COX-2, and PGIS, in which the inverse associations with NSAID use or fish intake were limited to certain genotype groups (37) (38) (39) (40) . Two EP2 tagSNPs included in this study, -616G>C and -166G>A, were associated with aspirinintolerant asthma in Korean individuals (59) . Although that study was small and 77 polymorphisms were tested without correction for multiple testing, those results indicate that polymorphisms in EP2 may be a predictor of who is likely to benefit from (or even experience adverse reactions from) aspirin. Two EP2 SNPs included in the present study (-1722A>G and -616G>C) were not associated with hypertension in a study of 266 Japanese subjects (60) and also were not associated with adenoma risk in the present study. In a recent whole genome association study of Crohn's disease, an inflammatory bowel condition, SNPs upstream of EP4 linked to altered EP4 expression were associated with increased risk (61) . However, these SNPs were not included in the present study because they are over 200KB upstream of EP4. In a study of lymphoma risk, three polymorphisms in PGES that were not included in this study (but one of which was tagged in our study by another SNP), were not associated with risk of lymphoma (62) .
This study has several limitations. First, a large number of statistical tests were performed, increasing the likelihood of false positives. Although we corrected for multiple testing, we chose to report the uncorrected p-values. However, given both the importance of PGE 2 for colorectal carcinogenesis and the fact that no one has yet reported on potential associations with tagSNPs in these genes for colorectal neoplasia risk, we decided to report all our findings for possible replication by other groups. Conversely, due to the relatively small number of study subjects, it is possible that true associations or gene-environment interactions were missed.
Intakes of specific types of fish were not measured in this study. Because fish vary in their content of n-3 polyunsaturated fatty acids, total fish intake is not a precise measure of n-3 polyunsaturated fatty acid intake. Further, we did not have a quantitative measure of dietary n-6 polyunsaturated fatty acids nor of fish oil or other fatty acid-containing supplements. This limited our power to detect true interactions between dietary fatty acids and genetic variability related to PGE 2 signaling on risk of colorectal adenoma.
This study has several strengths. First, all controls who participated in this study underwent colonoscopy prior to enrollment. Because colorectal polyps are common in older adults, an unscreened population-based control group would include undiagnosed adenoma cases, resulting in disease misclassification and an attenuation of any true associations. In addition, by using tagSNPs as well as rare non-synonymous SNPs to investigate associations between these target genes and risk of colorectal adenoma, we achieved comprehensive coverage of these genes, increasing the likelihood of observing any existing true association.
The prostaglandin synthesis pathway is an important one for colorectal carcinogenesis and our complete coverage of the genes and their 5' and 3' regions, as well as some lifestyle factors that are likely to influence prostaglandin synthesis, provides a more complete investigation of this pathway.
In summary, the results from the present study provide some limited evidence that genetic variability in genes related to PGE 2 levels and signaling may be modifiers of the relationship between NSAID use or fish intake and risk of colorectal adenoma. Figure 1 caption. PGES -664T>A, weekly fish intake, and risk of adenoma.
